BioCatch delivers behavioral biometrics by analyzing human-device interactions to protect users and financial systems from fraud and money laundering. Led by CEO Gadi Mazor and founded in 2011, the company is based in Tel Aviv, Israel. BioCatch reports over a decade of data-analysis experience and holds more than 60 patents. Its stated mission is to unlock the power of behavior and deliver actionable insights to create a digital world where identity, trust, and ease co-exist. The company says it continues to innovate to solve future problems. Financially, BioCatch has raised around $70M in the most recent financing and has raised $253M in total to date. BioCatch develops behavioral biometrics that analyze an online user's physical and cognitive digital behavior to protect users and their assets without collecting personally identifiable information. Its continuous-authentication products flag risky digital behavior and address onboarding fraud (stolen or synthetic identities), account takeovers, and sophisticated social-engineering scams. The company reports more than 150 million behavior profiles, tens of billions of transactions, and over 50 global patents accumulated since its founding in 2011. Customers around the globe leverage BioCatch's insights to fight fraud, drive digital transformation, and accelerate business growth. BioCatch has formed a Client Innovation Board with major financial institutions to develop and scale behavior-based solutions and industry-wide anti-fraud capabilities. The company recently expanded its financing as part of its ongoing Series C activity, bringing total capital raised to $168 million. BioCatch provides behavioral biometrics that analyze physical and cognitive digital interactions to protect online users and their data. The company passively monitors sessions for continuous authentication without collecting PII and flags anomalies such as stolen or synthetic identities at onboarding, account takeovers, and social engineering scams. It has compiled more than 150 million privacy-protected behavioral profiles and analyzes over 1 billion digital sessions per month in real time. BioCatch is deployed at more than 40 major global banks and other financial institutions worldwide and holds over 50 global patents. Founded in 2011 and operating out of New York & Tel Aviv, Israel, the company grew annual recurring revenues by 150% in 2019 and was on pace for similar growth in 2020. The company recently raised $145 million in a Series C. BioCatch develops behavioral biometric authentication and threat-detection technology that collects and analyzes more than 500 cognitive parameters to generate unique user profiles. Once installed on a bank's website or app, the technology uses those behavioral profiles to authenticate users and detect or prevent fraud, including phishing attacks and bots. Founded in 2011, the company highlights a portfolio of more than 56 granted or pending patents and has a recently appointed CEO, Howard Edelstein. BioCatch says it has focused on blue-chip customers, mostly large banks, and plans to broaden into adjoining sectors such as insurance, cryptocurrency, P2P payments, healthcare and government. The startup will invest in its product range, beginning with fraud detection during account opening, enabled by its accumulated behavioral data. Management cites rising market awareness and increased competition in behavioral biometrics over the past 24 months as a driver for the raise. BioCatch offers cloud-based behavioral authentication and threat-detection technology that analyzes over 400 bio-behavioral, cognitive and physiological parameters to create unique user profiles. Its platform integrates with existing security systems and is used by banks and eCommerce sites to reduce friction on risky transactions and protect against threats such as account takeovers, Man-in-the-Browser malware and remote access (RAT) attacks. The company also markets an enterprise tool to improve employee authentication experiences and safeguard access to critical IT assets. Led by CEO Benny Rosenbaum, BioCatch is headquartered in Boston, MA and currently employs 20 team members. The company completed a $10M financing and plans to use the funds to expand R&D and continue growth in key markets including the U.S. and Europe.

Total raised

$275M

Funding rounds

5

Latest round

Equity

Latest activity

Nov 2023